登海种业(002041) - 2015 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2015 was CNY 602,884,508.01, representing a 7.04% increase compared to CNY 563,213,430.73 in the same period last year[20]. - The net profit attributable to shareholders was CNY 179,530,505.00, which is a 9.94% increase from CNY 163,303,006.35 year-on-year[20]. - The net profit after deducting non-recurring gains and losses was CNY 176,732,740.52, up 10.38% from CNY 160,108,170.73 in the previous year[20]. - The basic earnings per share increased to CNY 0.2040, a rise of 9.91% from CNY 0.1856[20]. - The total assets at the end of the reporting period were CNY 3,702,656,927.39, down 6.25% from CNY 3,949,334,688.29 at the end of the previous year[20]. - The net assets attributable to shareholders increased to CNY 2,056,881,262.58, reflecting a 2.82% growth from CNY 2,000,550,757.58[20]. - The net cash flow from operating activities was negative at CNY -65,297,313.59, a significant decrease of 150.46% compared to CNY 129,392,967.11 in the same period last year[20]. - The weighted average return on equity was 9.03%, slightly down from 9.42% in the previous year[20]. Revenue and Profitability - The company achieved operating revenue of CNY 602.88 million, a year-on-year increase of 7.04%[31]. - The main business revenue reached CNY 601.16 million, with a growth of 7.58% compared to the previous year[35]. - The gross profit margin for the main business decreased by 2.28 percentage points to 53.22%[35]. - The company reported a total profit for the first half of 2015 was CNY 223,487,833.67, compared to CNY 200,447,771.57 in the previous year, reflecting an increase of 11.5%[124]. - The company's operating profit was CNY 220,572,547.86, which is a 11.0% increase from CNY 198,588,582.98 in the same period last year[124]. Investment and R&D - The company invested CNY 16.35 million in R&D, reflecting an increase of 11.06% year-on-year[31]. - The company made an investment of CNY 27.75 million in external equity investments during the reporting period[37]. - The company has applied for 131 variety rights and obtained 101, along with 17 patents, including 9 invention patents[36]. - The company invested CNY 765.06 million in non-public fundraising projects, with a total planned investment of CNY 12,379.23 million[60]. Cash Flow and Financial Management - The net cash flow from operating activities was -65,297,313.59 CNY, a decrease from 129,392,967.11 CNY in the previous period, indicating a significant decline in operational performance[131]. - Cash inflow from investment activities totaled 3,297,390,562.91 CNY, compared to 2,867,134,538.53 CNY in the prior period, reflecting an increase of approximately 15%[132]. - The total cash and cash equivalents at the end of the period were 326,609,427.60 CNY, down from 601,089,093.85 CNY, representing a decrease of about 46%[132]. - The company reported a financial expense of CNY -244,332.85, a significant improvement compared to CNY -6,035,618.78 in the previous year, indicating better financial management[124]. Shareholder and Dividend Information - The company plans not to distribute cash dividends or issue bonus shares for this period[5]. - The company distributed a cash dividend of RMB 3.5 per 10 shares (including tax) and issued 14 bonus shares per 10 shares, totaling a profit distribution of RMB 616 million[63]. - The total number of shares distributed was 528 million, with 492.8 million shares as bonus shares and 35.2 million shares from capital reserves[63]. - The company did not declare any cash dividends or issue bonus shares for the half-year period[65]. Subsidiaries and Market Expansion - The company established two new subsidiaries in Inner Mongolia and Shaanxi during the reporting period[33]. - The company invested in two new subsidiaries, Denghai Dixin and Denghai Liaohe, during the reporting period[92]. - The company signed a comprehensive strategic cooperation framework agreement with Zhongyu Jinbiaoji (Beijing) Biotechnology Co., Ltd.[92]. - The company is focusing on expanding its market presence through strategic investments and partnerships[51]. Compliance and Governance - The financial report for the half-year period was not audited[112]. - The company did not engage in any major litigation, arbitration, or asset transactions during the reporting period[70][72]. - The company has not made any new provisions for special reserves during the current period[145]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring the financial reports reflect a true and complete picture of its financial status[165]. Accounting Policies and Practices - The company applies fair value measurement for identifiable assets and liabilities acquired in business combinations, with goodwill recognized when the acquisition cost exceeds the fair value of net identifiable assets[170]. - Cash and cash equivalents are defined as cash on hand and deposits readily available for payment, ensuring high liquidity and minimal risk of value change[174]. - The company recognizes financial assets when the ownership risks and rewards are transferred to the transferee, and terminates recognition when control is relinquished[179].